Interpretable Chirality-Aware GNNs for QSAR Modeling in Drug Discovery | Yunchao (Lance) Liu

[DISCLAIMER] - For the full visual experience, we recommend you tune in through our YouTube channel to see the presented slides.

If you enjoyed this talk, consider joining the Molecular Modeling and Drug Discovery (M2D2) talks live.

Also, consider joining the M2D2 Slack.

Abstract: In computer-aided drug discovery, quantitative structure activity relation models are trained to predict biological activity from chemical structure. Despite the recent success of applying graph neural network to this task, important chemical information such as molecular chirality is ignored. To fill this crucial gap, we propose Molecular-Kernel Graph Neural Network (MolKGNN) for molecular representation learning, which features SE(3)-/conformation invariance, and interpretability. For our MolKGNN, we first design a molecular graph convolution to capture the chemical pattern by comparing the atom’s similarity with the learnable molecular kernels. Furthermore, we propagate the similarity score to capture the higher-order chemical pattern. To assess the method, we conduct a comprehensive evaluation with nine well-curated datasets spanning numerous important drug targets that feature realistic high class imbalance and it demonstrates the superiority of MolKGNN over other GNNs in CADD. Meanwhile, the learned kernels identify patterns that agree with domain knowledge, confirming the pragmatic interpretability of this approach. This work was recently accepted by AAAI23.

Speaker: Yunchao (Lance) Liu

Twitter -  Prudencio

Twitter - Therence

Twitter - Jonny

Twitter - Valence Discovery